Update on extraintestinal pathogenic E. coli vaccine phase 3 clinical study Independent interim analysis of the E.mbrace phase 3 study finds that the vaccine candidate didn't demonstrate sufficient ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback